Biosciences
Our researchers in have a rich legacy of collaboration with government agencies and industry partners that improve health outcomes and well-being around the world. SRI Biosciences projects range from high-impact, early-stage research to drug co-development with pharmaceutical and biotech companies.
-
Catching the rhythms of women’s health
The menstrual cycle has numerous biological effects on women. New SRI research asks: Could a better understanding of these patterns improve healthcare for women around the globe?
-
The hidden cost of springing forward
Daylight Savings Time is more than just an hour lost. How can we better prepare ourselves?
-
Major NIH study helps families manage sleep and screentime
SRI Fellow Fiona Baker: Longitudinal research like the SRI-supported ABCD study is crucial for understanding how modern life shapes developing brains.
-
SRI teams with Kalekona Radiotheranostics to deliver breakthrough therapies aimed at diagnosing and treating pancreatic cancer and glioblastoma
SRI’s FOX Three peptide platform to deliver precision radionuclide therapy targeted at hard-to-treat tumors.
-
SRI multi-party team selected as an awardee by ARPA-H to develop at-home screening for ≥30 types of cancers
The POSEIDON program aims to save millions of lives by detecting cancer early.
-
N4 Pharma and SRI demonstrate breakthrough in RNA cancer therapy
The collaboration paves the way for increased precision in cancer treatment.
-
SRI receives FDA clearance to initiate a clinical trial of high-dose naloxone
Researchers say the new formulation could reduce overdose fatalities caused by fentanyl and other synthetic opioids.
-
Helping pre-teens get the sleep they need
The American Academy of Sleep Medicine highlights SRI research focused on the relationship between parental engagement and pre-teen sleep.
-
Microbes make nutritious meals out of air
An SRI-led team has succeeded in creating a food product rich in essential nutrients, suitable for quickly scaling up disaster relief in remote locations.
-
The naked mole rat may hold the key to new treatments for neurodegenerative diseases
SRI researchers study the cells of the long-living rodent to find new drug targets for Alzheimer’s, Parkinson’s, and other neurodegenerative disorders.
-
Engineered helper T cell could become a cancer killer
SRI scientists are developing a cell-based platform using an often-undervalued subset of helper T cells to deliver potent antitumor proteins for solid tumors, overcoming dose-related toxicities.
-
SRI identifies predictors of adolescent obesity
As part of a nationwide longitudinal study of adolescent brain development, researchers use AI to analyze data to pinpoint obesity risk factors.